8-K current report · filed Sep 28, 2026

Inhibrx Biosciences, Inc. (INBX) 8-K Current Report: September 28, 2026

Item 7.01INBX overview

Short answer

Inhibrx Biosciences, Inc. (INBX) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 7.01 (Regulation FD Disclosure). Updated corporate presentation posted September 28, 2026, signaling refreshed investor messaging.

Inhibrx Biosciences, Inc. 8-K event analysis

AI summary of each reported item and its exhibits

Item 7.01 · Regulation FD Disclosure

  • Updated corporate presentation posted September 28, 2026, signaling refreshed investor messaging
  • Presentation likely summarizes current business updates for conferences and investor meetings
  • Investors should review Exhibit 99.1 for substantive pipeline, clinical, or corporate developments

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Inhibrx Biosciences, Inc. 8-K filings

Get the next INBX 8-K as it lands

Follow INBX for push alerts, or ask the research agent what this filing means.